Physician profile
Daniel Beyerbach
NPI 1932144888
$2,237.83
in general payments reported to CMS, 2019-2025
13 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $166 · 2021: $19.75 · 2022: $15.26 · 2023: $608 · 2024: $319 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $503.10 | 2019-2023 | |
| Atricure, INC. | $438.08 | 2019-2023 | |
| Biosense Webster, INC. | $292.25 | 2023-2024 | Carto 3 |
| Abbott Laboratories | $185.06 | 2023-2025 | Tacticath Ablation Catheter, Sensor Enabled, Agilis |
| Medtronic, INC. | $182.39 | 2022-2025 | Affera Mapping System, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $166.32 | 2019 | |
| Biotronik INC. | $138.92 | 2025 | Acticor 7 Vr-T Dx |
| Astrazeneca Pharmaceuticals Lp | $115.78 | 2020 | |
| Zoll Respicardia, INC. | $111.37 | 2019 | |
| Bardy Diagnostics, INC. | $50.00 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.92 | 2024 | Lifevest |
| Cardiva Medical, INC. | $19.75 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Beyerbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.